DarrenNeilSerilMD

Gastroenterology • New Brunswick, NJ

Advanced Endoscopic Interventional

Physician

Join to view full profile

Dr. Seril is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Seril's full profile

Already have an account?

Office
125 Paterson St
Clinical Academic Building Room 5100
New Brunswick, NJ 08901
Phone+1 732-235-7784

Fax+1 732-235-7792

Education & Training

Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolFellowship, Gastroenterology, 2010 - 2013
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2007 - 2010
Rutgers Robert Wood Johnson Medical SchoolClass of 2007

Certifications & Licensure

NJ State Medical License 2010 - 2025
NY State Medical License 2014 - 2018
OH State Medical License 2013 - 2016
PA State Medical License 2007 - 2010
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

The prevalence and impact of psychiatric comorbidities on hospitalized inflammatory bowel disease patients in the United States: insights from the National Inpatient S...
Marcella Pimpinelli, Abhishek Bhurwal, Sophia Pimpinelli, Hemant Mutneja, Carlos D Minacapelli
Annals of Gastroenterology. 2024-02-10
Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply.
Abhishek Bhurwal, Hemant Mutneja, Darren Seril
Alimentary Pharmacology & Therapeutics. 2022-07-01
16 citations
Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.
Abhishek Bhurwal, Hemant Mutneja, Vikas Bansal, Akshay Goel, Shilpa Arora
Alimentary Pharmacology & Therapeutics. 2022-05-01

Journal Articles

Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis
Janet Alvarez, Koushik K Das, Kiron M Das, Elizabeth Poplin, Darren N Seril, Digestive Diseases and Sciences

Press Mentions

Analysis Answers Questions Arising from Immunosuppressive Treatments — ScienceDailyApril 11th, 2022